Year archive

Primo Nutraceuticals Inc. — 2017 filings

All 23 regulatory filings released by Primo Nutraceuticals Inc. (BUGVF) in 2017, sourced directly from the official regulator.

23 Filings

2017 Period

2017 filings (23)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2017-12-29	English
Interim financial statements/report – English.pdf Regulatory Filings	2017-12-29	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2017-12-13	English
Preliminary Receipt.pdf Regulatory Filings	2017-12-12	English
Preliminary long form prospectus - English.pdf Regulatory Filings	2017-12-11	English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf Regulatory Filings	2017-12-09	English
Annual MD&A (amended) - English.pdf Regulatory Filings	2017-12-09	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2017-11-29	English
Annual MD&A - English.pdf Regulatory Filings	2017-11-29	English
Audited annual financial statements – English.pdf Regulatory Filings	2017-11-29	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2017-08-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2017-06-30	English
Interim MD&A - English.pdf Regulatory Filings	2017-06-30	English
Interim financial statements/report – English.pdf Regulatory Filings	2017-06-30	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2017-04-04	English
Interim MD&A - English.pdf Regulatory Filings	2017-04-04	English
Interim financial statements/report – English.pdf Regulatory Filings	2017-04-04	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2017-02-28	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2017-02-28	English
Interim financial statements/report – English.pdf Regulatory Filings	2017-02-28	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2017-02-28	English
Annual MD&A - English.pdf Regulatory Filings	2017-02-28	English
AB form 13-501F2 (class 2 reporting issuers - participation fee).pdf Regulatory Filings	2017-02-28	English